Scott J. Charles

Chief Financial Officer at Tribute Pharmaceuticals, Inc.

Scott J. Charles

Scott J. Charles

Chief Financial Officer at Tribute Pharmaceuticals, Inc.

Overview
Career Highlights

Tribute Pharmaceuticals, Inc.
Aralez Pharmaceuticals, Inc.
POZEN, Inc.

RelSci Relationships

155

Number of Boards

2

Birthday

1975

Age

44

Contact Data
Trying to get in touch with Scott J. Charles? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Scott J. Charles likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Secretary, Executive Vice President & General Counsel at Sunovion Pharmaceuticals, Inc.

Relationship likelihood: Strong

General Counsel & Chief Compliance Officer at Kala Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive Chairman at Nuvo Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Auxilium Pharmaceuticals LLC

Relationship likelihood: Strong

Former Director at Aralez Pharmaceuticals Canada, Inc.

Relationship likelihood: Strong

Director at Aralez Pharmaceuticals Canada, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at iBD Advisors, Inc.

Relationship likelihood: Strong

President at LMT Financial, Inc.

Relationship likelihood: Strong

President at Coolham Holdings, Inc.

Relationship likelihood: Strong

CAO, Vice President-Finance & Administration at POZEN, Inc.

Relationship likelihood: Strong

Paths to Scott J. Charles
Potential Connections via
Relationship Science
You
Scott J. Charles
Chief Financial Officer at Tribute Pharmaceuticals, Inc.
Education

Established in 1846 as the University at Lewisburg; renamed Bucknell University in 1886 in honor of William Bucknell, a major benefactor. The University is highly selective, private, nonsectarian, coeducational (since 1883), residential, and undergraduate, with a small graduate program.

Career History
Chief Financial Officer
2016 - Current

Tribute Pharmaceuticals is a specialty pharmaceutical company engaged in the acquisition, licensing and management of pharmaceuticals products in Canada.Tribute is committed to providing patients and physicians with clinically proven pharmaceuticals products that treat recognized medical conditions and diseases. Their goal is to provide quality products that improve patient outcomes.Tribute is seeking to expand its product portfolio in Canada through strategic partnerships with other pharmaceutical, biotechnology and specialty pharmaceutical companies interested in gaining market experience in Canada.

Chief Financial Officer, Senior Vice President
2016 - 2017

Aralez Pharmaceuticals Inc. focuses on the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the foolowing geographical segments: United States, and Canada. The company is founded on December 2, 2015 and is headquartered in Ontario, Canada.

Chief Financial Officer
2015 - 2016

POZEN, Inc. manufactures and markets pharmaceutical products. Its Pipeline products are PA Product Portfolio, which is focused on integrated aspirin therapies that enable the full power of aspirin by reducing its potential gastrointestinal damage. The firm PA Product Portfolio consists of PA8140 and PA32540. The company was founded by John R. Plachetka in 1996 and is headquartered in Raleigh, NC.

Boards & Committees
Treasurer & Vice President
2002 - Prior

Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ

Director
Tenure Unconfirmed

Aralez Pharmaceuticals Canada, Inc. operates as a pharmaceutical company which focuses on the acquisition, licensing, development, and promotion of healthcare products. It also sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The company was founded by Peter Roy Riehl and Robert Paul Harris on November 14, 1994 and is headquartered in Mississauga, Canada.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Scott J. Charles. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Scott J. Charles's profile does not indicate a business or promotional relationship of any kind between RelSci and Scott J. Charles.